Currently, there is no FDA-approved indication for GLP-1 receptor agonists in cognitive disorders or neuroprotection
Notably, deletion of the equilibrative nucleoside transporter 1 (ENT1) leads to reduced AQP4 expression, further linking purinergic signaling to astrocytic water channel regulation [422]
Combat GLP-1 and diet-related fatigue The Wegovy (semaglutide) patient information label by Novo Nordisk states that 11% of adults taking Wegovy 2.4 mg experience fatigue, and 8% felt dizzy
To keep things moving, you must pair your fiber intake with plenty of water
l-Arginine, a potent insulin secretagogue [309], also stimulates GLP-1 release from isolated rat intestine, and, when given orally, augments GLP-1 and insulin levels and improves glucose tolerance in mice, effects that are absent in GLP-1R KO mice [305]